CareDx, Inc.
CDNACareDx, Inc. (CDNA) is a molecular diagnostics company specializing in transplantation testing and monitoring. It develops and commercializes proprietary diagnostic products to improve graft survival and patient outcomes for organ transplant recipients. The company's offerings include assays for immune system monitoring and early detection of organ rejection, primarily serving the transplant community.
Company News
Johnson Fistel, a law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. for potential breaches of fiduciary duties and violations of federal securities laws. The investigation is related to CareDx's issuance of false and misleading public statements regarding its compliance with healthcare laws and...
The law firm Morris Kandinov is investigating several companies, including CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., and Tax Free Fund for Puerto Rico Residents, Inc., for potential breaches of fiduciary duties and other legal violations on behalf of shareholders.
Morris Kandinov, a national law firm, is investigating potential breaches of fiduciary duties and other legal violations by CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., and Tax Free Fund for Puerto Rico Residents, Inc. Shareholders are encouraged to contact the firm to learn more about the...
The liquid biopsy market is experiencing significant growth, driven by advancements in technology and increasing demand for non-invasive diagnostic methods. North America is the largest market, with a 48.11% share in 2023. Key drivers include increased benefits over conventional biopsy, rising cancer incidence, and technological advancements, whi...
This report analyzes the global market for laboratory-developed tests (LDTs), including the impact of new FDA regulations introduced in 2024. It covers the LDT services market and the market for LDT products sold to clinical laboratories, with a focus on key segments like infectious disease and oncology.
